Matthew Gantz
-
More Skin in the Game: Exton’s Castle Creek Biosciences Makes Acquisition Weeks After Canceling IPO Plans
Weeks after canceling its IPO plans, Exton-based Castle Creek Biosciences has acquired Novavita Thera, a Minnesota-based preclinical gene therapy company that focuses on rare liver…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
